1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ALG6 CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA TTF1 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA FOXI3 CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA ASB14 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA REEP5 CTRPv2 pan-cancer AAC -0.18 3e-06
mRNA LEMD3 CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA DCAKD CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA ZNF784 CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA EFNA2 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA TOP2A CTRPv2 pan-cancer AAC 0.16 3e-06
Download CSV